PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-1.96%
Revenue decline while ZETA shows 0.00% growth. Joel Greenblatt would examine competitive position erosion.
-0.06%
Cost reduction while ZETA shows 0.00% growth. Joel Greenblatt would examine competitive advantage.
-2.81%
Gross profit decline while ZETA shows 0.00% growth. Joel Greenblatt would examine competitive position.
-0.87%
Margin decline while ZETA shows 0.00% expansion. Joel Greenblatt would examine competitive position.
1.15%
R&D change of 1.15% while ZETA maintains spending. Bruce Berkowitz would investigate effectiveness.
-25.54%
G&A reduction while ZETA shows 0.00% growth. Joel Greenblatt would examine efficiency advantage.
-12.60%
Marketing expense reduction while ZETA shows 0.00% growth. Joel Greenblatt would examine competitive risk.
85.12%
Other expenses change of 85.12% while ZETA maintains costs. Bruce Berkowitz would investigate efficiency.
-8.60%
Operating expenses reduction while ZETA shows 0.00% growth. Joel Greenblatt would examine advantage.
-4.42%
Total costs reduction while ZETA shows 0.00% growth. Joel Greenblatt would examine advantage.
-4.78%
Interest expense reduction while ZETA shows 0.00% growth. Joel Greenblatt would examine advantage.
1.61%
D&A change of 1.61% while ZETA maintains D&A. Bruce Berkowitz would investigate efficiency.
-3.29%
EBITDA decline while ZETA shows 0.00% growth. Joel Greenblatt would examine position.
4.86%
Margin change of 4.86% while ZETA is flat. Bruce Berkowitz would examine quality.
2.27%
Income change of 2.27% while ZETA is flat. Bruce Berkowitz would examine quality.
4.31%
Margin change of 4.31% while ZETA is flat. Bruce Berkowitz would examine quality.
-100.00%
Other expenses reduction while ZETA shows 0.00% growth. Joel Greenblatt would examine advantage.
0.71%
Income change of 0.71% while ZETA is flat. Bruce Berkowitz would examine quality.
2.73%
Margin change of 2.73% while ZETA is flat. Bruce Berkowitz would examine quality.
439.76%
Tax expense change of 439.76% while ZETA maintains burden. Bruce Berkowitz would investigate strategy.
-19.03%
Net income decline while ZETA shows 0.00% growth. Joel Greenblatt would examine position.
-17.40%
Net margin decline while ZETA shows 0.00% growth. Joel Greenblatt would examine position.
-18.60%
EPS decline while ZETA shows 0.00% growth. Joel Greenblatt would examine position.
-19.30%
Diluted EPS decline while ZETA shows 0.00% growth. Joel Greenblatt would examine position.
-0.27%
Share count reduction while ZETA shows 0.00% change. Joel Greenblatt would examine strategy.
-0.26%
Diluted share reduction while ZETA shows 0.00% change. Joel Greenblatt would examine strategy.